Advertisement

International Journal of Colorectal Disease

, Volume 31, Issue 7, pp 1315–1321 | Cite as

Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis

  • Soichiro Ishihara
  • Yukihide Kanemitsu
  • Koji Murono
  • Kensuke Otani
  • Koji Yasuda
  • Takeshi Nishikawa
  • Toshiaki Tanaka
  • Junichiro Tanaka
  • Tomomichi Kiyomatsu
  • Kazushige Kawai
  • Keisuke Hata
  • Hioaki Nozawa
  • Shinsuke Kazama
  • Hironori Yamaguchi
  • Eiji Sunami
  • Kenichi Sugihara
  • Toshiaki Watanabe
Original Article

Abstract

Purpose

We aimed to clarify the prognostic impact of lateral pelvic lymph node (LPN) dissection (LPND) for rectal cancer through a multicenter retrospective study using propensity score analysis.

Methods

A total of 1238 patients with pathological T2-4, M0 rectal cancer who had undergone curative operation between 2007 and 2008 were examined. Majority of the patients (96 %) were treated without preoperative chemoradiotherapy (CRT). Clinical background data of the patients treated with LPND and those treated without LPND were matched using propensity scores, and hazard ratios (HRs) for cancer-specific mortality were compared.

Results

LPND was performed more frequently for lower rectal cancers and in patients with more advanced disease, and 29 % of the patients were treated with LPND. After matching background features by propensity scores, LPND did not correlate with improved cancer-specific survival (CSS) among the entire study population [HR, 0.73; 95 % confidence interval (CI) 0.41–1.31; P = 0.28]; however, LPND was correlated with significantly improved CSS in female patients (HR, 0.23; 95 % CI, 0.06–0.89; P = 0.04) but not in male patients (HR, 0.95; 95 % CI, 0.48–1.89; P = 0.89). The results were similar when patients treated with LPND finally diagnosed as pathologically negative for LPN metastasis were compared with those curatively treated without LPND.

Conclusions

It is suggested that the prognostic impact of LPND for rectal cancer treated without CRT might be different between sexes, and LPND should be considered for female rectal cancer patients although they are diagnosed as clinically negative for LPN metastasis.

Keywords

Rectal cancer Lateral pelvic lymph node dissection Surgery Propensity score analysis 

Notes

Acknowledgments

This study is based on the data from 19 hospitals which are members of the Japanese Society for Cancer of the Colon and Rectum: First Department of Surgery, Sapporo Medical University; Department of Surgery, Hirosaki University; Division of Digestive and General Surgery, Niigata University; Department of Surgery, National Defense Medical College; Department of Surgery, Tochigi Cancer Center; Department of Surgery, Kyorin University; Department of Surgery, Tokyo Metropolitan Komagome Hospital; Department of Surgery II, Tokyo Women’s Medical University; Department of Surgery, International Medical center of Japan; Department of Surgery, Keio University; Department of Surgery, Teikyo University; Department of Surgical Oncology, Tokyo Medical and Dental University; Colorectal Surgery Division, National Cancer Center Hospital; Department of Surgical Oncology, The University of Tokyo; Department of Surgery, Fujita Health University; Department of Gastroenterological Surgery, Aichi Cancer Center Research Institute; Department of Surgery, Kyoto University; Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases; Department of Surgery, Kurume University; Department of Surgery, Hyogo College of Medicine

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishihara S, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Boku N, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K (2015) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 20(2):207–239. doi: 10.1007/s10147-015-0801-z CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49(11):1663–1672. doi: 10.1007/s10350-006-0714-z CrossRefPubMedGoogle Scholar
  3. 3.
    Moriya Y, Sugihara K, Akasu T, Fujita S (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21(7):728–732CrossRefPubMedGoogle Scholar
  4. 4.
    Mori T, Takahashi K, Yasuno M (1998) Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg / Dtsch Ges Chir 383(6):409–415CrossRefGoogle Scholar
  5. 5.
    Ueno H, Mochizuki H, Hashiguchi Y, Hase K (2001) Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg 234(2):190–197CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Shirouzu K, Ogata Y, Araki Y, Sasatomi T, Nozoe Y, Nakagawa M, Matono K (2001) Total mesorectal excision, lateral lymphadenectomy and autonomic nerve preservation for lower rectal cancer: significance in the long-term follow-up study. Kurume Med J 48(4):307–319CrossRefPubMedGoogle Scholar
  7. 7.
    Shimoyama M, Yamazaki T, Suda T, Hatakeyama K (2003) Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2. Dis Colon Rectum 46(3):333–339. doi: 10.1097/01.DCR.0000049446.90416.B9 CrossRefPubMedGoogle Scholar
  8. 8.
    Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T (2005) Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92(6):756–763. doi: 10.1002/bjs.4975 CrossRefPubMedGoogle Scholar
  9. 9.
    Hojo K, Koyama Y, Moriya Y (1982) Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 144(3):350–354CrossRefPubMedGoogle Scholar
  10. 10.
    Moriya Y, Hojo K, Sawada T, Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32(4):307–315CrossRefPubMedGoogle Scholar
  11. 11.
    Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Sugihara K (2009) Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum 52(4):567–576. doi: 10.1007/DCR.0b013e3181a1d994 CrossRefPubMedGoogle Scholar
  12. 12.
    Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U (2005) Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23(24):5644–5650. doi: 10.1200/JCO.2005.08.144 CrossRefPubMedGoogle Scholar
  13. 13.
    Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693–701. doi: 10.1097/01.sla.0000257358.56863.ce CrossRefPubMedGoogle Scholar
  14. 14.
    Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11):1114–1123. doi: 10.1056/NEJMoa060829 CrossRefPubMedGoogle Scholar
  15. 15.
    Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24(28):4620–4625. doi: 10.1200/JCO.2006.06.7629 CrossRefPubMedGoogle Scholar
  16. 16.
    Sauer I, Bacon HE (1952) A new approach for excision of carcinoma of the lower portion of the rectum and anal canal. Surg Gynecol Obstet 95(2):229–242PubMedGoogle Scholar
  17. 17.
    Bacon HE, Dirbas F, Myers TB, Ponce De Leon F (1958) Extensive lymphad enectomy and high ligation of the inferior mesenteric artery for carcinoma of the left colon and rectum. Dis Colon Rectum 1(6):457–464, discussion 464–455CrossRefPubMedGoogle Scholar
  18. 18.
    Stearns MW Jr, Deddish MR (1959) Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum 2(2):169–172CrossRefPubMedGoogle Scholar
  19. 19.
    Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10(11):1053–1062. doi: 10.1016/S1470-2045(09)70224-4 CrossRefPubMedGoogle Scholar
  20. 20.
    Kim TG, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK (2014) Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients. Int J Colorectal Dis 29(2):193–200. doi: 10.1007/s00384-013-1797-3 CrossRefPubMedGoogle Scholar
  21. 21.
    Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, Chang HJ, Lim SB, Choi HS, Park JG (2008) Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15(3):729–737. doi: 10.1245/s10434-007-9696-x CrossRefPubMedGoogle Scholar
  22. 22.
    Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H, Oya M, Yamaguchi T, Watanabe T, Muto T (2014) Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 21(1):189–196. doi: 10.1245/s10434-013-3216-y CrossRefPubMedGoogle Scholar
  23. 23.
    Kotake K, Mizuguchi T, Moritani K, Wada O, Ozawa H, Oki I, Sugihara K (2014) Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis 29(7):847–852. doi: 10.1007/s00384-014-1885-z CrossRefPubMedGoogle Scholar
  24. 24.
    Ishihara S, Hayama T, Yamada H, Nozawa K, Matsuda K, Miyata H, Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kanazawa T, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Hashiguchi Y, Sugihara K, Watanabe T (2014) Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study. Ann Surg Oncol. doi: 10.1245/s10434-014-3719-1 Google Scholar
  25. 25.
    Austin PC (2013) The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med 32(16):2837–2849. doi: 10.1002/sim.5705 CrossRefPubMedGoogle Scholar
  26. 26.
    Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging—a meta-analysis. Radiology 232(3):773–783. doi: 10.1148/radiol.2323031368 CrossRefPubMedGoogle Scholar
  27. 27.
    Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K (2012) Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg 255(6):1129–1134. doi: 10.1097/SLA.0b013e3182565d9d CrossRefPubMedGoogle Scholar
  28. 28.
    Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y (2012) Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 13(6):616–621. doi: 10.1016/s1470-2045(12)70158-4 CrossRefPubMedGoogle Scholar
  29. 29.
    Fujita S, Yamamoto S, Akasu T, Moriya Y (2003) Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 90(12):1580–1585. doi: 10.1002/bjs.4350 CrossRefPubMedGoogle Scholar
  30. 30.
    Ishihara S, Hayama T, Yamada H, Nozawa K, Matsuda K, Miyata H, Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kanazawa T, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Hashiguchi Y, Sugihara K, Watanabe T (2014) Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study. Ann Surg Oncol 21(9):2949–2955. doi: 10.1245/s10434-014-3719-1 CrossRefPubMedGoogle Scholar
  31. 31.
    Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44(9):1274–1280CrossRefPubMedGoogle Scholar
  32. 32.
    Watanabe T, Tsurita G, Muto T, Sawada T, Sunouchi K, Higuchi Y, Komuro Y, Kanazawa T, Iijima T, Miyaki M, Nagawa H (2002) Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery 132(1):27–33CrossRefPubMedGoogle Scholar
  33. 33.
    Mukai T, Akiyoshi T, Ueno M, Fukunaga Y, Nagayama S, Fujimoto Y, Konishi T, Ikeda A, Yamaguchi T (2013) Laparoscopic total pelvic exenteration with en bloc lateral lymph node dissection after neoadjuvant chemoradiotherapy for advanced primary rectal cancer. Asian J Endosc Surg 6(4):314–317. doi: 10.1111/ases.12047 CrossRefPubMedGoogle Scholar
  34. 34.
    Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol 23(25):6199–6206. doi: 10.1200/JCO.2005.14.779 CrossRefPubMedGoogle Scholar
  35. 35.
    Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23(25):6126–6131. doi: 10.1200/jco.2005.02.543 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Soichiro Ishihara
    • 1
  • Yukihide Kanemitsu
    • 2
  • Koji Murono
    • 1
  • Kensuke Otani
    • 1
  • Koji Yasuda
    • 1
  • Takeshi Nishikawa
    • 1
  • Toshiaki Tanaka
    • 1
  • Junichiro Tanaka
    • 1
  • Tomomichi Kiyomatsu
    • 1
  • Kazushige Kawai
    • 1
  • Keisuke Hata
    • 1
  • Hioaki Nozawa
    • 1
  • Shinsuke Kazama
    • 1
  • Hironori Yamaguchi
    • 1
  • Eiji Sunami
    • 1
  • Kenichi Sugihara
    • 3
  • Toshiaki Watanabe
    • 1
  1. 1.Department of Surgical OncologyThe University of TokyoTokyoJapan
  2. 2.Colorectal Surgery DivisionNational Cancer Center HospitalTokyoJapan
  3. 3.Department of Surgical OncologyTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations